| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| James Patrick Kelly | EVP CFO and Treasurer | 2026-03-07 | 5,904 | $9.98 | $58.92kSell |
| Elaine Ohara | EVP Chief Strategy Officer | 2026-03-03 | 22,429 | $9.49 | $212.85kSell |
| Mark J. Casey | EVP Chief Legal Officer | 2026-03-03 | 11,378 | $9.49 | $107.98kSell |
| Ruxandra Draghiaakli | EVP Research Development | 2026-03-03 | 11,313 | $9.49 | $107.36kSell |
| Ruxandra Draghiaakli | EVP Research Development | 2026-03-03 | 11,313 | $9.49 | $107.36kSell |
| John C. Jacobs | President and CEO | 2026-03-03 | 69,288 | $9.49 | $657.54kSell |
| James Patrick Kelly | EVP CFO and Treasurer | 2026-03-03 | 20,850 | $9.49 | $197.87kSell |
| Elaine Ohara | EVP Chief Strategy Officer | 2026-03-01 | 10,969 | $10.14 | $111.23kSell |
| John C. Jacobs | President and CEO | 2026-03-01 | 38,450 | $10.14 | $389.88kSell |
| John C. Jacobs | President and CEO | 2026-03-01 | 38,450 | $10.14 | $389.88kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 9.41% | 15,470,365 | $144.80M | Institution |
| Shah Capital Management | 8.85% | 14,558,780 | $136.27M | Institution |
| Blackrock Inc | 7.85% | 12,901,549 | $120.76M | Institution |
| State Street Corp | 5.79% | 9,523,646 | $89.14M | Institution |
| Cadila Pharmaceuticals Ltd | 5.78% | 9,500,000 | $88.92M | Insider |
| Bank Of America Corp | 5.04% | 8,290,665 | $77.60M | Institution |
| Sanofi | 4.18% | 6,880,481 | $64.40M | Institution |
| James B. 1. Tananbaum | 3.81% | 6,268,455 | $58.67M | Insider |
| D E Shaw Co Inc | 3.64% | 5,992,798 | $56.09M | Institution |
| Ubs Group Ag | 2.98% | 4,894,284 | $45.81M | Institution |